According to data released by the Swedish Health Authority, from September 1-16, Sweden had an average of 198 new cases of coronary pneumonia diagnosed and 1.5 deaths per day. This is the lowest level in Europe. According to an analysis by the European Center for Disease Prevention and Control (ECDC), 22.2 Swedes per 100,000 were diagnosed in the last two weeks, significantly lower than in Spain (279), France (158), and the Czech Republic (118). It has been argued that Sweden’s choice of the so-called “mass immunization” strategy may have worked, unlike European countries such as Britain and France, which have implemented lockdown policies.
According to Chosun Ilbo, the mass immunization trial resulted in a significant reduction in the number of infections in Sweden. Since the early days of the Neocon epidemic, Sweden has not taken any compulsory vaccination measures, except for a ban on gatherings of more than 50 people. As a result, Sweden has been considered a country that has pursued mass immunization at the governmental level, although it has not publicly stated so.
According to the World Health Organization (WHO), if 70% of the population is cured of the disease or acquires antibodies to the new coronavirus through vaccination, the neo-crown epidemic will die down and so-called collective immunity will be achieved. Last month, Sweden’s director of public health said, “Sweden’s antibody possession rate is approaching 30 percent, and the effect (of collective immunity) is gradually appearing.
However, South Korean experts believe that it is not easy to choose a collective immunization strategy at the national level when the new vaccine is not yet available and the duration of antibodies is unclear, the report said. According to a professor of infectious diseases at Seoul National University School of Medicine, “There has never been a precedent where a collective immunity was formed through natural infection without a vaccine, which eventually brought an infection epidemic to an end.” Coupled with the recent worldwide number of cases of cured neoconjugates coming back positive, some studies suggest that the duration of immunity through antibodies may be as little as three months.
The dramatic increase in deaths is also a problem. According to a professor of infectious diseases at Hanlin University, “The result of Sweden’s stubborn resistance to the blockade is a death toll of 5,860 for a population of 10 million so far. Some calculations say that if South Korea adopts the Swedish model, it could result in 30,000 deaths.”
Recent Comments